Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
36303858	u-kiteet	— (—)	68	78	98.72%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Calculus of kidney and ureter

15.35

14.36

1.2

1.1

—

Urolithiasis

15.35

14.36

1.2

1.1

—

Chronic kidney disease

14.13

13.22

1.1

1.3

—

Renal failure

9.68

12.31

1.1

1.2

—

Acute renal failure

10.92

6.79

1.2

—

Codeine

4.63

6.31

1.1

—

Dialysis, with operation codes

18.03

6.26

1.2

1.0

—

Any gastric operation

5.35

6.22

1.1

1.2

—

GASTRO-related operations

5.35

6.22

1.1

1.2

—

Codeine or tramadol medication

3.67

6.20

1.1

1.2

—

Bacterial Sepsis

5.41

6.02

1.2

1.1

—

Implicit bacterial Sepsis

5.72

5.97

1.3

1.1

—

Implicit Sepsis

3.90

5.85

1.2

1.1

—

Genitourinary diseases

7.80

5.65

1.1

1.0

—

Implicit Sepsis, including avohilmo

3.78

5.57

1.1

—

Implicit bacterial Sepsis, including avohilmo

5.12

5.48

1.3

1.1

—

Condition for Implicit Sepsis (Organ dysfunction codes)

3.67

5.31

1.1

—

Persons encountering health services in other circumstances

5.85

5.16

1.2

1.1

—

Care involving dialysis

13.36

5.08

1.3

1.0

—

L04AD Calcineurin inhibitors

13.35

5.07

1.3

1.0

—

Dental caries

8.58

5.07

1.2

—

Implicit viral Sepsis

6.88

4.94

1.3

1.2

—

Viral Sepsis

6.88

4.94

1.3

1.2

—

Caries of dentine

9.64

4.90

1.2

—

Tramadol

5.01

4.79

1.1

—

Diseases of the digestive system

4.48

4.51

1.1

1.2

—

Viral and other specified intestinal infections

7.99

4.48

1.2

1.1

—

Opioids

3.75

4.40

1.1

—

Other symptoms and signs involving the urinary system

11.68

4.27

1.1

1.0

—

Hydronephrosis

11.68

4.27

1.3

1.0

—

Transplanted organ and tissue status

11.68

4.27

1.3

1.0

—

Implicit viral Sepsis, including avohilmo

5.49

4.27

1.3

1.2

—

L04AA Selective immunosuppressants

6.43

3.98

1.2

1.1

—

Other antidepressants

3.03

3.90

1.2

1.1

—

Endocrine, nutritional and metabolic diseases

3.61

3.90

1.1

—

Viral and other specified intestinal infections, including avohilmo

6.19

3.86

1.2

1.1

—

COPD/asthma/ILD related infections

3.00

3.64

1.1

1.2

—

COPD/asthma related infections

3.00

3.64

1.1

1.2

—

Certain infectious and parasitic diseases

3.21

3.56

1.1

—

Nephropathy related operations

10.01

3.49

1.3

1.0

—

Other acute lower respiratory infections

3.64

3.49

1.0

1.2

—

Symptoms and signs involving speech and voice

5.00

3.36

1.1

1.2

—

Pain, not elsewhere classified

5.00

3.36

1.0

1.1

—

Persons encountering health services for specific procedures and health care

2.61

3.22

1.2

1.1

—

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

2.89

3.16

1.1

—

Gout, idiopatic and unspecified

4.50

3.11

1.0

1.1

—

All influenza

5.00

3.04

1.1

1.2

—

Acute bronchitis

3.60

3.01

1.1

—

Kidney transplant status

10.02

2.98

1.4

1.0

—

Persons encountering health services for specific procedures, not carried out

10.01

2.98

1.2

1.0

—

Other diseases of upper respiratory tract

2.54

2.97

1.2

1.1

—

Congenital malformations of genital organs

9.94

2.96

1.0

1.2

—

Persons with potential health hazards related to communicable diseases

3.81

2.94

1.0

1.2

—

Acute upper respiratory infections of multiple and unspecified sites

2.84

2.93

1.1

1.2

—

Gout, FINNGEN

4.07

2.86

1.0

1.1

—

Noninfective enteritis and colitis

3.33

2.80

1.0

1.2

—

Intestinal stricture

3.91

2.77

1.1

—

Voice disturbances

5.00

2.72

1.1

—

Depression or dysthymia

3.53

2.70

1.1

—

COPD differential diagnosis

3.16

2.65

1.0

1.1

—

ILD differential diagnosis

3.16

2.65

1.0

1.1

—

Excluding asthma or asthma-COPD overlap

3.16

2.65

1.0

1.1

—

Other pulmonary diagnosis

3.16

2.65

1.0

1.1

—

Ulcerative colitis

4.67

2.59

1.0

1.1

—

Certain infectious and parasitic diseases, including avohilmo

3.44

2.59

1.1

—

Erysipelas, including avohilmo

2.96

2.55

1.2

1.1

—

Substance use, excluding alcohol

5.46

2.54

1.0

1.1

—

Hypo-osmolality and hyponatraemia

7.09

2.53

1.0

1.3

—

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

2.73

2.50

1.0

1.2

—

Gout, unspecified

4.38

2.47

1.0

1.1

—

Sequelae of external causes of morbidity and mortality

4.38

2.47

1.4

1.1

—

Irregular menses

4.00

2.46

1.4

1.1

—

Other diseases of the digestive system

3.81

2.46

1.1

—

Other abnormal uterine and vaginal bleeding

5.39

2.38

1.2

1.0

—

Diseases of the respiratory system

3.76

2.38

1.1

1.0

—

Radiculopathy

6.25

2.37

1.0

1.1

—

Hernia of abdominal wall, postoperative

6.21

2.36

1.2

1.1

—

Candidiasis, including avohilmo

4.12

2.36

1.0

1.1

—

Congenital malformations, deformations and chromosomal abnormalities

2.82

2.32

1.0

1.2

—

Excessive, frequent and irregular menstruation

4.67

2.32

1.4

1.0

—

Coagulation defects, purpura and other haemorrhagic conditions

4.62

2.27

1.0

1.1

—

Cutaneous abscess, furuncle and carbuncle

3.89

2.25

1.3

1.2

—

Paralytic ileus and intestinal obstruction

3.89

2.25

1.0

1.2

—

Other reaction to severe stress, and adjustment disorders

3.89

2.25

1.0

1.1

—

Any reimbursement code in KELA

3.47

2.22

1.1

1.2

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

2.30

2.21

1.1

1.2

—

Superficial injury of shoulder and upper arm

5.56

2.21

1.2

1.1

—

Noninfectious colitis NAS

5.56

2.21

1.0

1.1

—

Substance abuse, excluding more controls

2.88

2.17

1.1

—

Any event in cancer register

2.40

2.09

1.1

1.2

—

Other and unspecified iron deficiency

3.19

2.08

1.0

1.2

—

Suppurative and unspecified otitis media

3.22

2.07

1.1

—

Sequelae with surgical and medical care as external cause

5.00

2.07

1.4

1.1

—

All influenza (not pneumonia)

5.00

2.07

1.2

1.1

—

All anxiety disorders

2.77

2.06

1.2

1.1

—

Strabismus

3.49

2.04

1.0

1.1

—

Myalgia

4.00

2.04

1.0

1.2

—

Anxiety (asthma-related co-morbidities)

2.71

2.01

1.2

1.1

—

GI-bleeding

3.33

1.96

1.1

—

Chronic rhinitis, nasopharyngitis and pharyngitis

3.33

1.96

1.4

1.0

—

Viral infections characterized by skin and mucous membrane lesions

2.73

1.92

1.3

1.1

—

Other diseases of hard tissues of teeth

2.91

1.88

1.1

1.3

—

Inflammatory bowel disease

3.18

1.88

1.0

1.1

—

Diseases of liver

3.18

1.88

1.1

—

Dental pulpitis, including avohilmo

2.24

1.87

1.1

1.2

—

Erysipelas

2.67

1.85

1.1

—

Other and unspecified anaemias

2.64

1.84

1.2

—

Other fall from one level to another

3.53

1.83

1.2

1.1

—

Glomerular diseases

4.17

1.82

1.4

1.2

—

Phlebitis and thrombophlebitis (not including DVT)

4.17

1.82

1.0

1.2

—

Nonorganic sleeping disorders, excluding more controls

4.17

1.82

1.0

1.2

—

Primary open-angle glaucoma, strict

4.16

1.82

1.0

1.3

—

Other anaemias

2.55

1.77

1.2

—

Other anxiety disorders

2.98

1.72

1.1

—

Bipolar affective disorders

3.85

1.71

1.2

1.1

—

Exclusions for E4_PCOS_BROAD

3.84

1.71

1.0

1.1

—

Deviated nasal septum

3.15

1.66

1.2

1.0

—

Necrosis of pulp, including avohilmo

2.47

1.65

1.1

1.2

—

Diseases of middle ear and mastoid

2.47

1.65

1.2

—

Insulin, fast-acting

2.80

1.64

1.3

1.1

—

Substance abuse

2.44

1.64

1.1

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

2.54

1.62

1.4

1.1

—

Malignant neoplasm

2.27

1.62

1.2

1.1

—

Malignant neoplasm

2.27

1.62

1.2

1.1

—

Periapical abscess

2.50

1.59

1.0

1.2

—

Mental and behavioural disorders due to psychoactive substance use

2.35

1.59

1.1

—

Localized swelling, mass and lump of skin and subcutaneous tissue

3.00

1.58

1.2

1.1

—

Obesity, other/unspecified

3.00

1.58

1.2

—

Mouth breathing

2.69

1.57

1.1

1.2

—

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

3.46

1.56

1.0

1.1

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

2.79

1.56

1.0

1.1

—

Subjective visual disturbances

3.33

1.52

1.0

1.1

—

Adverse effects, not elsewhere classified

3.33

1.52

1.4

1.1

—

Other noninfective gastroenteritis and colitis

3.33

1.52

1.0

1.1

—

Other viral diseases, not elsewhere classified

3.32

1.52

1.2

1.0

—

Insulin, fast-acting or short human

2.59

1.51

1.3

1.1

—

Non-selective monoamine reuptake inhibitors

2.88

1.51

1.0

1.2

—

Other viral diseases

2.85

1.50

1.3

1.1

—

Triptan medication for migraine, min. 3 purchases

2.49

1.49

1.3

1.1

—

Other obstetric conditions, not elsewhere classified

3.50

1.48

1.2

1.3

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

3.50

1.48

1.2

1.3

—

Diseases of the eye and adnexa

2.30

1.47

1.2

1.1

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

2.62

1.46

1.0

1.2

—

Acute suppurative otitis media

2.80

1.46

1.0

1.1

—

Asthma

2.44

1.45

1.0

1.1

—

Other benign neoplasms of skin

2.50

1.45

1.1

—

Factors influencing health status and contact with health services

3.59

1.44

1.0

—

Other and unspecified tonsillitis

2.77

1.42

1.0

1.1

—

Malignant neoplasm, including Hilmo

2.12

1.41

1.2

1.1

—

Malignant neoplasm, wide definition

2.12

1.41

1.2

1.1

—

Obesity related asthma

2.61

1.36

1.0

1.2

—

Disease of hard tissues of teeth, NOS

2.62

1.36

1.3

—

Nonorganic sleeping disorders

2.94

1.36

1.0

1.1

—

2.14

1.33

1.0

1.2

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

2.14

1.33

1.0

1.2

—

Provisional assignment of new diseases of uncertain etiology

2.12

1.32

1.3

1.2

—

Codes for special purposes

2.12

1.32

1.3

1.2

—

Insulin, intermediate and long-acting

2.12

1.31

1.2

1.1

—

Asthma (only as main-diagnosis), excluding more controls

2.46

1.31

1.0

1.1

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

2.50

1.30

1.3

1.1

—

Asthma (only as main-diagnosis)

2.35

1.27

1.0

1.1

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

2.27

1.26

1.1

—

Keratitis

2.40

1.24

1.2

1.1

—

Asthma, excluding more controls

2.28

1.23

1.0

1.1

—

Other viral diseases, including avohilmo

2.38

1.22

1.3

1.2

—

Mycoses

2.63

1.21

1.0

1.1

—

Other viral diseases, not elsewhere classified, including avohilmo

2.62

1.20

1.2

1.1

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

2.14

1.20

1.0

1.2

—

Asthma (mode)

2.21

1.19

1.0

1.1

—

Autoimmune diseases excluding thyroid diseases

1.85

1.17

1.1

—

Other medical care

2.10

1.17

1.1

1.2

—

Malignant neoplasm of skin

2.49

1.16

1.0

1.2

—

Malignant neoplasm of skin, including Hilmo

2.34

1.12

1.0

1.2

—

Used for control exclusion in common control thyroid runs

1.81

1.09

1.1

—

Unspecified haematuria

2.19

1.07

1.0

1.1

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

2.35

1.07

1.2

—

Gastrointestinal diseases

2.19

1.05

1.0

1.1

—

2.01

1.05

1.2

1.1

—

Solid cancers

1.95

1.00

1.1

—

1.86

0.99

1.2

1.1

—

1.98

0.99

1.1

1.3

—

Solid cancers, including Hilmo

1.94

0.98

1.1

—

Other and unspecified effects of external causes

2.17

0.98

1.4

1.1

—

Asthma-related pneumonia

2.21

0.93

1.2

—

Asthma, hospital admissions 3, pneumonia

2.21

0.93

1.2

—

Asthma-related pneumonia or sepsis

2.21

0.93

1.2

—

Autoimmune diseases excluding thyroid diseases, strict definition

1.72

0.91

1.2

1.1

—

Other inflammation of eyelid, including avohilmo

2.07

0.89

1.3

1.2

—

Diseases of male genital organs

1.83

0.85

1.0

1.1

—

Autoimmune diseases

1.65

0.85

1.1

1.2

—

Other diseases of lip and oral mucosa

1.94

0.84

1.0

1.1

—

Delivery, wide proxy

0.00

0.83

0.0

1.3

—

Diseases of oral cavity, salivary glands and jaws

1.93

0.81

1.0

1.3

—

Alzheimer disease, including avohilmo

0.00

0.81

0.0

1.2

—

Degenerative diseases of the nervous system

0.00

0.80

0.0

1.2

—

Covid-19 confirmed case

1.82

0.79

1.5

1.2

—

Acute sinusitis

1.82

0.78

1.2

1.1

—

Neoplasms

1.75

0.77

1.1

1.2

—

Injury, poisoning and certain other consequences of external causes

1.95

0.77

1.1

—

COPD, hospital admission 2, with asthma infections

2.15

0.76

1.0

1.1

—

Abnormal findings on examination of blood, without diagnosis

1.86

0.74

1.3

1.1

—

Disorders of the thyroid gland

1.62

0.73

1.2

1.1

—

Kela-code for severe mental illness

2.00

0.72

1.2

1.1

—

Abnormal serum enzyme levels

1.93

0.70

1.2

1.0

—

Diseases of external ear

1.92

0.70

1.0

1.1

—

Asthma, unspecified (mode)

1.90

0.69

1.0

1.1

—

Senile cataract

1.70

0.69

1.0

1.1

—

Unspecified mental disorder

1.85

0.68

1.2

1.1

—

External causes of morbidity and mortality

1.67

0.67

1.1

1.0

—

Diseases of the skin and subcutaneous tissue

1.58

0.65

1.0

1.2

—

Disorders of lens

1.71

0.64

1.0

1.1

—

Alzheimer’s disease, strict definition

0.00

0.61

0.0

1.2

—

Pregnancy, childbirth and the puerperium

0.00

0.61

0.0

1.2

—

Alzheimer’s disease (Late onset)

0.00

0.61

0.0

1.2

—

Use of other anti-dementia drugs

0.00

0.61

0.0

1.2

—

Use of memantine

0.00

0.61

0.0

1.2

—

Other hearing loss

0.00

0.60

0.0

1.1

—

Alzheimer disease

0.00

0.59

0.0

1.2

—

Exclusions for E4_PCOS_CONSORTIUM

1.51

0.58

1.1

1.2

—

COPD, hospital admissions

1.74

0.58

1.2

1.0

—

COPD, early/later onset

1.74

0.58

1.2

1.0

—

Other diseases of pleura

1.74

0.58

1.0

1.1

—

Mental and behavioural disorders due to alcohol

1.59

0.54

1.2

1.1

—

Selective serotonin reuptake inhibitors

1.57

0.54

1.2

1.1

—

Inguinal hernia

1.60

0.50

1.3

1.1

—

Chronic diseases of tonsils and adenoids

1.52

0.48

1.3

1.1

—

Hypothyroidism, strict autoimmune

1.46

0.43

1.1

—

Antenatal screening

0.00

0.42

0.0

1.4

—

Dementia in Alzheimer disease

0.00

0.41

0.0

1.2

—

Postpartum hemorraghe, parous women as controls

0.00

0.41

0.0

1.2

—

Obesity due to excess calories

1.52

0.41

1.2

—

Hydrocele

0.00

0.41

0.0

1.1

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

0.00

0.41

0.0

1.1

—

Lichen ruber planus, wide definition including periferal and oral lichen planus

0.00

0.41

0.0

1.1

—

Postpartum hemorraghe, all women as controls

0.00

0.41

0.0

1.3

—

Status post-ami

0.00

0.40

0.0

1.1

—

Hypothyroidism, other/unspecified

1.43

0.39

1.1

—

Combinations of oral blood glucose lowering drugs

0.00

0.39

0.0

1.1

—

Open wound of wrist and hand

1.38

0.38

1.0

1.1

—

Alcohol use disorder, Swedish definition

1.33

0.33

1.3

1.1

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

1.34

0.28

1.1

—

Hernia of abdominal wall

1.32

0.23

1.2

1.1

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

1.25

0.22

1.2

—

Other menopausal disorders

0.00

0.22

0.0

1.0

—

Traumatic subdural haemorrhage

0.00

0.21

0.0

1.1

—

Childhood allergy (age < 16)

0.00

0.21

0.0

1.3

—

Presbycusis

0.00

0.21

0.0

1.0

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

0.00

0.21

0.0

1.0

—

Pedal cyclist injured in noncollision transport accidents

0.00

0.21

0.0

1.1

—

Bell's palsy

0.00

0.21

0.0

1.1

—

Superficial injury of ankle and foot

0.00

0.21

0.0

1.1

—

Myopia

0.00

0.21

0.0

1.1

—

Injury of muscle and tendon at lower leg level

0.00

0.21

0.0

1.2

—

Use of rivastigmine

0.00

0.21

0.0

1.1

—

Leisure time condition

0.00

0.21

0.0

1.1

—

Acute appendicitis, no complications

1.18

0.21

1.2

1.1

—

Ulcerative colitis (strict definition, all Crohn cases excluded)

0.00

0.21

0.0

1.1

—

Injury of eye and orbit

0.00

0.21

0.0

1.1

—

Superficial injury of thorax

0.00

0.21

0.0

1.1

—

Migraine with aura and triptan purchases

0.00

0.21

0.0

1.1

—

Pre-eclampsia

0.00

0.21

0.0

1.3

—

Benign neoplasm: Rectum, anus and anal canal

0.00

0.21

0.0

1.1

—

Pre-eclampsia or eclampsia

0.00

0.21

0.0

1.3

—

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

0.00

0.21

0.0

1.1

—

Ganglion

0.00

0.21

0.0

1.2

—

Supervision of high-risk pregnancy

0.00

0.20

0.0

1.4

—

Long labour

0.00

0.20

0.0

1.2

—

Ulcerative colitis (strict definition, require KELA)

0.00

0.20

0.0

1.1

—

Seborrhoeic keratosis

0.00

0.20

0.0

1.1

—

Postpartum haemorrhage

0.00

0.20

0.0

1.3

—

Gestational [pregnancy-induced] hypertension

0.00

0.20

0.0

1.3

—

Gastroduodenal ulcer

0.00

0.20

0.0

1.1

—

Benign neoplasms

1.24

0.17

1.1

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

1.19

0.17

1.1

—

Acute appendicitis

1.09

0.09

1.2

1.1

—

Appendicitis, broad definition

1.05

0.08

1.2

1.1

—

Diseases of appendix

1.05

0.08

1.2

1.1

—

Disorders of optic nerve and visual pathways

0.00

0.0

1.1

—

Benign neoplasm: Skin of other and unspecified parts of face

0.00

0.0

1.0

—

Female infertility

0.00

0.0

1.0

—

Benign neoplasm: Transverse colon

0.00

0.0

1.0

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Crystals [Presence] in Urine

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS